Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
on a two-year, National Institutes of Health (NIH)-funded Phase II study to investigate and validate the use of small peptides that target the visceral pain in irritable bowel syndrome (IBS)
In healthy cells, FOXO4 binds to p53
Abnousian A, Vasquez J, Sasaninia K, Kelley M, Venketaraman V
These circadian clock genes significantly influence the adaptive ROS threshold across different circadian phases
requires clinic visit or self-injection training
US$ 28.68
US$ 27.53
US$ 27.73
US$ 25.79
US$ 26.00
